Akero Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 7.38 M | $205.23 M | -6.58% | 10.62% |
| RTW INVESTMENTS, LP | 02/14/2025 | 6.86 M | $190.84 M | 15.89% | 9.88% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 6.03 M | $167.77 M | -14.74% | 8.69% |
| BLACKROCK, INC. | 02/07/2025 | 5.92 M | $164.81 M | 3.07% | 8.53% |
| GENERAL ATLANTIC, L.P. | 02/07/2025 | 5.23 M | $145.61 M | 0.00% | 7.54% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 4.32 M | $120.24 M | 13.49% | 6.22% |
| VANGUARD GROUP INC | 02/11/2025 | 3.70 M | $103.06 M | 0.76% | 5.33% |
| STATE STREET CORP | 02/14/2025 | 2.34 M | $64.99 M | -6.67% | 3.36% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 1.84 M | $51.17 M | -8.82% | 2.65% |
| ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.76 M | $49.00 M | -47.03% | 2.54% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.56 M | $43.40 M | -0.72% | 2.25% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 1.49 M | $41.45 M | 116.01% | 2.15% |
| CITADEL ADVISORS LLC | 02/14/2025 | 1.35 M | $37.69 M | 803.86% | 1.95% |
| REDMILE GROUP, LLC | 02/14/2025 | 1.24 M | $34.36 M | -10.97% | 1.78% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 1.19 M | $32.98 M | -30.86% | 1.71% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 1.10 M | $30.52 M | 0.00% | 1.58% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 946,499 | $26.33 M | 1.40% | 1.36% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 899,680 | $25.03 M | -30.97% | 1.30% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 800,000 | $22.26 M | 0.00% | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 739,563 | $20.57 M | 15.59% | 1.07% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 02/14/2025 | 719,604 | $20.02 M | 0.00% | 1.04% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 670,048 | $18.64 M | -48.46% | 0.96% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 02/11/2025 | 666,145 | $18.53 M | -12.21% | 0.96% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 649,134 | $18.06 M | 100.00% | 0.93% |
| NORTHERN TRUST CORP | 02/14/2025 | 620,321 | $17.26 M | 6.11% | 0.89% |
| PFIZER INC | 02/14/2025 | 562,626 | $15.65 M | 100.00% | 0.81% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 540,692 | $15.04 M | 1.52% | 0.78% |
| JPMORGAN CHASE & CO | 02/12/2025 | 528,207 | $14.69 M | 8.23% | 0.76% |
| EMERALD ADVISERS, LLC | 02/11/2025 | 520,114 | $14.47 M | -0.82% | 0.75% |
| MORGAN STANLEY | 02/14/2025 | 471,535 | $13.12 M | 5.24% | 0.68% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 460,617 | $12.81 M | 17.34% | 0.66% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 457,524 | $12.73 M | -30.92% | 0.66% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 449,110 | $12.49 M | 6,229.06% | 0.65% |
| UNIVERSITY OF WISCONSIN FOUNDATION | 02/13/2025 | 410,630 | $11.42 M | -3.12% | 0.59% |
| WOODLINE PARTNERS LP | 02/14/2025 | 379,967 | $10.57 M | 29.92% | 0.55% |
| UBS GROUP AG | 02/14/2025 | 371,844 | $10.34 M | 292.24% | 0.54% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 02/14/2025 | 365,000 | $10.15 M | 100.00% | 0.53% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/14/2025 | 352,180 | $9.80 M | -15.18% | 0.51% |
| PROPEL BIO MANAGEMENT, LLC | 02/14/2025 | 343,729 | $9.56 M | 0.00% | 0.50% |
| RHEOS CAPITAL WORKS INC. | 01/24/2025 | 276,000 | $7.68 M | 0.00% | 0.40% |
| MARSHALL WACE, LLP | 02/13/2025 | 275,074 | $7.65 M | 100.00% | 0.40% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 273,811 | $7.62 M | -18.42% | 0.39% |
| ABRDN PLC | 01/24/2025 | 269,782 | $7.51 M | 118.70% | 0.39% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/11/2025 | 264,677 | $7.36 M | -6.73% | 0.38% |
| FRED ALGER MANAGEMENT, LLC | 02/14/2025 | 263,353 | $7.33 M | -2.32% | 0.38% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 262,295 | $7.30 M | -5.76% | 0.38% |
| 02/14/2025 | 260,000 | $7.23 M | 100.00% | 0.37% | |
| CUTTER CAPITAL MANAGEMENT, LP | 02/14/2025 | 230,000 | $6.40 M | 100.00% | 0.33% |
| JANE STREET GROUP, LLC | 02/14/2025 | 225,019 | $6.26 M | 3.43% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 200,430 | $5.58 M | -3.10% | 0.29% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akero Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 216 institutional investors and hedge funds held shares of Akero Therapeutics, Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 7.38 M
RTW INVESTMENTS, LP: 6.86 M
JANUS HENDERSON GROUP PLC: 6.03 M
BlackRock, Inc.: 5.92 M
GENERAL ATLANTIC, L.P.: 5.23 M
PRICE T ROWE ASSOCIATES INC /MD/: 4.32 M
106.82% of Akero Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 87.74 M shares in the last 24 months. This purchase volume represents approximately $3.22 B in transactions.